
Duke Cancer
@dukecancer
Cancer creates its own rules. We recognized ending cancer requires a weapon as adaptable & multiform as the disease itself—Duke Cancer Institute.
ID: 74160820
http://dukecancerinstitute.org 14-09-2009 13:52:37
7,7K Tweet
16,16K Followers
1,1K Following

DCI's David J. Casarett, MD, spoke with Medscape about how hospitalists can best communicate cancer prognoses with patients. duke.is/j/a26z Duke Health | Duke University School of Medicine

On the Sick & Good Podcast, Duke Psychiatry's Dr. Caroline Dorfman discussed barriers for onco-fertility & reproductive preservation. They also chatted about challenges adolescents & young adult #cancer face re: maintaining well-being. Listen: ow.ly/zRMe50VKx3Y Duke Cancer


New guidance has been issued by ASTRO on radiation therapy for anal cancer patients, a first of its kind. DCI's Brian Czito, MD, chaired the task force that led to this guidance. duke.is/4/phyq Duke Radiation Oncology | Duke Health


Congratulations to Erik Sulman, MD, PhD, on being named the new chair of the Department of Radiation Oncology at Duke University School of Medicine. duke.is/r/7me6 Duke University School of Medicine | Duke Radiation Oncology

Duke is the only center in the Southeast currently using a single-port robotic system for thoracic surgeries. These systems offer fewer incisions, faster healing time for lung cancer patients. duke.is/v/4x9s Duke Health | #LungCancer

New research from a team at Duke has found high-risk screenings for #BreastCancer may not be necessary in older patients with certain BRCA mutations, potentially reducing unnecessary stress and procedures. duke.is/8/fgeq Duke Health | Duke University School of Medicine | Duke Surgery


The Hugo™ robotic-assisted surgery (RAS) system is safe and effective, according to late-breaking data presented by DCI's Michael Abern, MD, at the 2025 Amer. Urol. Assn. meeting. duke.is/v/9hv3 Duke Health | Duke Surgery | Duke Urology

Researchers at Duke have found a weakness in synovial #Sarcoma that suggests a possible new treatment for the disease. duke.is/2/vwjx Duke Health | Duke University School of Medicine | Duke Pharmacology & Cancer Biology Department

Mustafa Khasraw, MD, deputy director of the DCI Center for Cancer Immunotherapy, is at the forefront of a promising clinical trial aimed at improving outcomes for patients with #Glioblastoma. duke.is/p/uuna Preston Robert Tisch Brain Tumor Center @ Duke | Duke Health | DukeIntegrativeImmunobiology | Duke Pharmacology & Cancer Biology Department


DCI's growing radiotheranostics program offers targeted treatment options for patients with #ProstateCancer, and potentially other cancers in the future. duke.is/n/8n3j Duke Health

From The V Foundation for Cancer Research: Learn how DCI's Christine E. Eyler, MD, PhD, balances being a groundbreaking researcher and devoted mother. duke.is/n/snkg #ColorectalCancer | Duke Health | Duke Radiation Oncology


Duke’s PRIME PREP Program provides a year of research experience to recent Duke University School of Medicine undergraduates. For Gabriella Torres, the program helped achieve her goal of being accepted into the Duke PhD program in integrative immunobiology. duke.is/j/8ewf


🎉 Congratulations to DCI members Matthew Labriola, MD, and Andrea Sitlinger, MD, on receiving 2025 Excellence in Education Awards from Duke Department of Medicine! duke.is/8/u2wk

After being diagnosed with triple-negative #BreastCancer, Arlene Brown started a treatment plan at Duke Health, guided by her oncology and obstetrics teams. Two years later, the proud mom of a beautiful toddler has no signs of recurrence. duke.is/b/ah3d Duke Health

The combination of enzalutamide with androgen deprivation therapy significantly increases the chance of five-year survival for men with metastatic hormone-sensitive #ProstateCancer, according to the global ARCHES study led by the DCI. duke.is/w/ppf9 Duke Health


Congratulations to DCI's Rodger Liddle, MD, on receiving this year's Career Achievement Award from Duke Department of Medicine! duke.is/c/8bfe

A new study led by DCI's Hui-Kuan Lin, PhD reveals an unexpected role for the protein ALDH4A1 that reshapes what scientists know about how our cells generate energy and fend off cancer. duke.is/w/satv Duke University School of Medicine

New research from a team of experts at Duke Center for Brain and Spine Metastasis highlights the use of AI and computational methods to differentiate between local recurrence and radionecrosis in #BrainMetastasis patients. duke.is/4/v7s2 Duke University School of Medicine | Duke Health

DCI has received the Notice of Award for the renewal of its Cancer Center Support Grant from National Cancer Institute, providing funding and reaffirming its position as one of the premier cancer centers in the United States. duke.is/p/r7bs Duke Health | Duke University School of Medicine